AIP
SNNA

Ameritas Investment Partners’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Ameritas Investment Partners’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,275
Closed -$3K – 3166
2019
Q1 		$3K Hold
1,275
– – ﹤0.01% 2936
2018
Q4 		$3K Hold
1,275
– – ﹤0.01% 2933
2018
Q3 		$19K Hold
1,275
– – ﹤0.01% 2549
2018
Q2 		$19K Hold
1,275
– – ﹤0.01% 2555
2018
Q1 		$24K Buy
1,275
+850
+200% +$14.9K ﹤0.01% 2344
2017
Q4 		$8K Buy
+425
New +$8.99K ﹤0.01% 2824

Other funds holding SNNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameritas Investment Partners's SNNA Position: Q2 2019 in Review

Ameritas Investment Partners sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q2 2019, closing a stake of 1,275 shares — an estimated $3K sold.

Ameritas Investment Partners first reported a position in SNNA in Q4 2017 and held it in 6 quarters. The position peaked at $24K in Q1 2018. 48 funds tracked by Wall St. Rank hold SNNA as of Q2 2019.

  • Ameritas Investment Partners reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,275 Sienna Biopharmaceuticals, Inc. shares in Q2 2019, an estimated $3K.
  • Ameritas Investment Partners first reported a position in Sienna Biopharmaceuticals, Inc. in Q4 2017 and held it in 6 quarters.
  • Ameritas Investment Partners's Sienna Biopharmaceuticals, Inc. position peaked at $24K in Q1 2018.
  • 48 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q2 2019.

Based on Ameritas Investment Partners's 13F filing for Q2 2019, filed 14 Aug 2019.